GENE ONLINE|News &
Opinion
Blog

Funding
Saudi Arabia to Invest $3.4 Billion in Latest Push to Develop Biotechnology Presence
2022-06-29
Brain Freeze, Iceland Based Pharma Company Gets Funding for ADHD R&D
2022-06-24
Human Longevity Plans to Merge With Blank Check Company to Go Public
2022-06-22
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
Akero Receives Up To $125 Million To Continue Liver Disease Treatment Development
2022-06-17
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
UK Launches World-First Program With Two Antimicrobial Drugs to Counter Superbugs
2022-06-16
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Elektrofi Secures $40 Million in Series B Funding For Drug Delivery Development
2022-06-15
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
Ultima Genomics Promises $100 Genome After Raising $600 Million
2022-06-01
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
1 2 3 4 5 6 11
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top